SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-17-004609
Filing Date
2017-03-16
Accepted
2017-03-16 16:01:17
Documents
3
Period of Report
2017-03-16
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K EARNINGS RELEASE fate-8k_20170316.htm 8-K 31207
2 EX-99.1 fate-ex991_35.htm EX-99.1 170952
3 GRAPHIC g2017031619072784740171.jpg GRAPHIC 3659
  Complete submission text file 0001564590-17-004609.txt   208534
Mailing Address 3535 GENERAL ATOMICS COURT SUITE 200 SAN DIEGO CA 92121
Business Address 3535 GENERAL ATOMICS COURT SUITE 200 SAN DIEGO CA 92121 858.875.1803
FATE THERAPEUTICS INC (Filer) CIK: 0001434316 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36076 | Film No.: 17694424
SIC: 2836 Biological Products, (No Diagnostic Substances)